These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3527011

  • 1. The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.
    Bell RC, Mullins RC, West LG, Bachand RT, Johanson WG.
    Ann Intern Med; 1986 Sep; 105(3):342-6. PubMed ID: 3527011
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
    Gothe B, Cherniack NS, Bachand RT, Szalkowski MB, Bianco KA.
    Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
    [Abstract] [Full Text] [Related]

  • 3. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
    Wuttke R, von Wichert P.
    Respiration; 1985 Mar; 48(4):285-95. PubMed ID: 3936140
    [Abstract] [Full Text] [Related]

  • 4. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C, Howard P, Ansquer JC.
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [Abstract] [Full Text] [Related]

  • 5. Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
    Watanabe S, Kanner RE, Cutillo AG, Menlove RL, Bachand RT, Szalkowski MB, Renzetti AD.
    Am Rev Respir Dis; 1989 Nov; 140(5):1269-73. PubMed ID: 2683905
    [Abstract] [Full Text] [Related]

  • 6. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
    Préfaut C, Bourgouin-Karaouni D, Ramonatxo M, Michel FB, Macabies J.
    Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A review of clinical studies carried out in Italy with almitrine bismesylate.
    Grassi V, Tantucci C, Sorbini CA, Grassi C, Cerveri I, Rampulla C, Bottino G, Giacometti A, Blasi A, Pezza A.
    Eur J Respir Dis Suppl; 1986 Jan; 146():671-6. PubMed ID: 3536560
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Almitrine bismesylate and hypoxemia in COPD patients (results of an Italian multicentric trial).
    Vulterini S, Dardes N, Moreo GC, Chianese R, Maiorano V, Carnimeo N.
    Eur J Respir Dis Suppl; 1986 Jan; 146():677-83. PubMed ID: 3536561
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
    Bardsley PA, Howard P, DeBacker W, Vermeire P, Mairesse M, Ledent C, Radermecker M, Bury T, Ansquer J.
    Eur Respir J; 1991 Mar; 4(3):308-10. PubMed ID: 1907566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.